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Abstract
Background: A transient postoperative drop in platelet count is an expected finding after aortic valve replacement 
using extracorporeal circulation. The implantation of the Perceval valve has been associated with a more intense drop of pla-
telet count compared to other bio-prostheses. This study analyses and compares the platelets progression associated with the 
Perceval and Intuity valves. 
Methods: The data was collected retrospectively for patients submitted to isolated aortic valve replacement with the 
Perceval valve (80 patients) and the Intuity valve (141 patients) in our institution between March 2014 and December 2018. 
The groups were further divided into those who receive platelet transfusion and those who did not.
Results: The minimum values of platelet count were 54% and 67% of the preoperative platelet count in the patients 
treated with a Perceval and an Intuity valves, respectively (p<0.001). In the patients transfused with platelets, the minimum 
values were 52% and 79% of the preoperative platelet count, respectively (p<0.01). Recovery of the count was faster in the 
patients treated with an Intuity valve. Abnormal bleeding and transfusion of packed red blood cells were not significantly 
different between groups (without platelet transfusion: p=0.71 and p=0.99, respectively; with platelet transfusion: p=0.58 
and p=0.99, respectively).
Conclusion: Compared to the Intuity valve, the Perceval valve is associated with a transient, but significant, drop in 
platelet count. This drop was not associated to an increased risk of bleeding. Platelet transfusion, in this setting, should be 
judicious and not only ruled by absolute values.
INTRODUCTION
The biologic rapid deployment valves were develo-
ped for aortic valve replacement surgery, as an alternative 
for high risk patients.1 At the moment, two models are 
available on the market: Perceval S (Sorin Group Salug-
gia, Italy / Livanova, London, UK) and Intuity (Edwards 
Lifesciences, Irvine, California, USA). By allowing a faster 
implantation with minimal heart and aorta manipulation, 
they provide shorter operative times, reduced periopera-
tive complications and better clinical outcomes maintai-
ning excellent hemodynamic performances.2,3,4 
A transient platelet drop is an expected posto-
perative finding. A reduction of 30-60% of the baseline 
values is common between the second and third days 
and is generally associated to the extracorporeal circu-
lation.5 A low count of platelets, particularly if severe, 
has the potential for bleeding complications, among 
others6. Additionally, the use of the Perceval valve has 
been associated with a more intense reduction and 
slower recovery of the platelet count and a higher need 
of packed red blood cells transfusion.7,8
The goals of this study were (1) to analyze the 
postoperative platelet response to Perceval and Intuity 
valves, (2) to compare the responses between the valves, 




Population and study groups
A total of 224 consecutive patients underwent 
isolated Intuity or Perceval valve implantation, between 
March 2014 and December 2018, at our institution. The 
indication for surgery was the same as for conventional 
aortic valve replacement. The data from all the patients 
was retrospectively reviewed. 
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Multisystemic failure is a well-known factor of coagu-
lation disturbance; for this reason, three patients were exclu-
ded due to rapid progressively multisystemic failure resulting 
in death. 
To avoid the effect of platelet transfusion in the 
progression of the platelet levels, the patients that received 
platelet transfusion after surgery were analyzed separately. 
Therefore, four groups were established: (1) patients that 
received an Intuity valve and no postoperative platelet trans-
fusion (IG, n=102); (2) patients that received a Perceval 
valve and no postoperative platelet transfusion (PG, n=60); 
(3) patients that received an Intuity valve and postoperative 
platelet transfusion (IpG, n=39); and (4) patients that recei-
ved a Perceval valve and postoperative platelet transfusion 
(PpG, n=20). 
Valve prostheses characteristics and implantation 
techniques 
INTUITY9
The Intuity valve is a bioprosthesis with three bovine 
pericardial leaflets. Its design was based on the Magna Ease 
aortic bioprosthesis (Edwards Lifesciences, Irvine, California, 
USA) built on a covered expandable stainless-steel frame, 
at the bottom side of the valve. This cloth skirt is intended 
to expand in the left ventricular outflow tract subjacent to 
the native annulus; this way, it promotes stability and sealing 
between the aortic annulus and the frame and host tissue 
in-growth. 
The anticalcification technology used is ThermaFix, a 
combination of both thermal and chemical agents developed 
to remove unstable glutaraldehyde residuals, the same used in 
other Edwards prostheses (such as Magna and Magna Ease).
After rinsing, the valve is connected to the specialized 
delivery system. Three guiding sutures, placed in the anulus 
at the nadir of each coronary cusps, pass though sewing ring 
in the valve and are used to align the valve with the annu-
lus during the descent. Once in position, the three sutures 
are secured using tourniquets. The balloon is inflated to the 
appropriate pressure (varying according to the valve size). The 
delivery system is removed and the guiding sutures are tied. 
PERCEVAL S9
The Perceval S valve is a bioprosthesis with three bovine 
pericardial leaflets mounted on a naked nitinol self-expanda-
ble frame; this frame is coated with CarbofilmTM to improve 
biocompatibility. Its design was based on the Freedom SOLO 
(Sorin Group Saluggia, Italy / Livanova, London, UK).
The anticalcification treatment is based on homocys-
teic acid, the same used in other Livanova prostheses (such as 
Pericarbon Freedom and Freedom SOLO).
The valve is compressed by a proper collapsing device 
and loaded onto the delivery device. No rinsing is required. 
Three guiding sutures help to align the valve with the annu-
lus during the descent into subannular position. The valve 
then is released from the delivery device and balloon dilata-
tion is performed at 4 atm of pressure for 30 seconds with 
continuous irrigation with sterile water at 37ºC. The guiding 
sutures are removed afterwards. The valve is kept in position 
by the stent against the intra-aortic wall.
Surgery and postoperative care
All patients were submitted to the same conventional 
surgical technique. The cardiopulmonary bypass was establi-
shed with an arterial cannula in the ascending aorta, a dou-
ble stage venous cannula through the right atrial appendage, 
and a left ventricle vent, placed through the right upper 
pulmonary vein. Cold blood cardioplegia was administered 
in an anterograde fashion. Complete decalcification of the 
aortic annulus was always performed. The choice of valve 
was made by the surgeon. At the end of the surgery, platelet 
and fresh plasma was administrated, if needed, according to 
clinical factors (such as, the amount of bleeding, the visual 
absence of clotting, and diffuse bleeding with no surgical 
explanation) and thromboelastography. Perioperative transe-
sophageal echocardiogram was performed in all patients to 
confirm valve position, hemodynamics and to exclude para-
valvular leaks.
Postoperative medication was the same for all 
patients, and started within 24h, according to the standard 
protocol of the department. It includes aspirin, statin, ace-
taminophen, metamizole, prophylactic enoxaparin, insulin 
(as needed), prophylactic cefazolin (or vancomycin if allergy), 
furosemide, pantoprazole, ondansetron (as needed), ami-
nergic support (epinephrine, norepinephrine and/or dobuta-
mine, as needed).
Platelet count measurements followed the standard 
routine of the department: within 24h previously to the sur-
gery, within 1h after surgery; in the mornings of the following 
days; and at the 1-month follow-up visit. 
Abnormal bleeding was defined as > 2ml/kg/h in first 
2-3 hours, > 1ml/kg/h in the next 3 hours and/or > 0.5ml/
kg/h in 12 hours.  A thromboelastography was performed 
to guide the choice of products to transfuse. If the bleeding 
rate was worrisome and no clot was visible in the drainage, 
both platelets and fresh plasma were transfused before the 
thromboelastography results. If the bleeding rate was great 
and/or causing hemodynamic instability, a surgical explora-
tion would be quickly performed.
Statistical analysis
Data collection and statistical analysis was carried out 
using SPSS v24. Continuous variables were treated as mean 
and standard deviation and compared with t-student tests, 
with a two-tailed distribution assuming unequal variances. 
Categorical variables were summarized as the number and/or 




Patients that did not received postoperative plate-
let transfusion
The baseline characteristics for IG and PG are 
presented in Table 1. Overall, the two groups were not 
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different. The two exceptions were the higher mean age 
in the PG (a difference of 1.8 years, p=0.04) and the 
higher frequency of coronary disease in the IG (a diffe-
rence of 18 percental points, p=0.02).
The differences in mean aorta cross clamping, 
extracorporeal circulation and operative times, between 
the groups, were, respectively, 1.5, 3.8 and 9.0 minutes, 
in favor of the IG (table 2). No relevant paravalvular leaks 
were found in any patients, in either group. Mean post 
implantation mean transvalvular gradient was 10.0 ± 3.7 
mmHg with the Intuity valve and 8.9 ± 5.2 mmHg with 
the Perceval valve (p=0.458).
Platelet count progression for each group is presen-
ted in Image 1A. Preoperative means were 225 ± 68/ml in 
the IG and 217 ± 61/ml in the PG. In the first hour, there 
was a significant drop (p<0.001), in both groups, to about 
70% of the preoperative count. In the following mornings, 
platelet count continued to decrease in the PG to a mini-
mum of 53.8% (at the 3rd postoperative day). In the IG, after 
a small increase, the numbers dropped to a minimum of 
67.2% of the preoperative count, 2 days after surgery. At 
the follow-up visit, the IG and PG presented a mean count 
of 123% and 98% of the preoperative count, respectively.
No statistically significant differences occurred 
between IG and PG regarding abnormal bleeding, blee-
ding related complications, in-hospital stay, major renal 
dysfunction, infection or death (see Table 2 for details).
A subanalysis excluding the patients with coronary 
disease was conducted. No relevant baseline differen-
ces were found. The differences in platelet progression 
remained similar. Abnormal bleeding occurred in 3.1% 
and 6.1% (p=0.65), in the patients implanted with an 
Intuity valve (n=65) and a Perceval valve (n=49), respec-
tively; transfusion of packed red blood cells was perfor-
med in 9.2% and 12.2% (p=0.760) and transfusion of 
fresh plasma occurred in 7.7% and 2.0% (p=0.234), res-
pectively. Major renal dysfunction was higher in the PG 
(10.0% vs 1.5%, p=0.083).
Patients that received postoperative platelet transfu-
sion
The IpG received a mean of 1.38 units of platelets 
per patient and the PpG a mean of 1.45 units per patient, 
within the first day. No statistically significant differences 
were found in baseline characteristics and surgical outco-
mes (tables 1 and 2). 
Table 1 Base characteristics. 









Sex (female/male) 61/39 % 53/47 % 0.411 41/59 % 40/60 % 0.999
Age (years) 74.8 ± 5.6 76.6 ± 4.8 0.040 76.6 ± 6.7 77.7 ± 5.7 0.566
EuroScore II (%) 2.4 ± 1.4 2.5 ± 1.9 0.651 2.1 ± 1.2 2.8 ± 1.9 0.179
Arterial hypertension 94.1% 93.3% 0.999 92.3% 100% 0,544
Dyslipidemia 78.4% 76.7% 0.846 74.4% 75.0% 0,999
Impaired renal function1 78.4% 86.7% 0.216 82.1% 85.0% 0.999
Overweigh/obesity2 76.5% 80.0% 0.697 66.7% 75.0% 0.565
Coronary disease 36.3% 18.3% 0.020 43.6% 50.0% 0,784
Diabetes Mellitus 36.3% 43.3% 0.407 30.8% 35.0% 0,775
Insulin treated 2.9% 8.3% 0.148 0% 0%
Atrial fibrillation3 18.6% 28.3% 0.173 15.4% 20.0% 0.721
Smoking history4 29.6% 26.7% 0.331 15.4% 20.0% 0.721
Thrombocytopenia5 7.8% 10.0% 0.773 30.8% 30% 0.999
Carotid disease 11.8% 8.3% 0.601 12,8% 5.0% 0,653
Pacemaker 4.9% 3.3% 0.999 5.1% 5% 0.999
Previous stroke or 
transient ischemic attack 3.9% 10.0% 0.175 7.7% 5% 0.999
Categorical variables are presented as percentage of subjects in each category and compared with t-student tests. Continuous variables were treated as mean and standard deviation 
and compared with Fisher’s exact tests.
1 Impaired renal function was defined as glomerular filtration rate <80%.
2 Overweigh/obesity was defined as body mass index >25.
3 Any form: paroxysmal, persistent, permanent.
4 Former or active.
5 Thrombocytopenia was defined as a platelet level <150/ml.
REVISTA PORTUGUESA DE CIRURGIA CARDIO-TORáCICA E VASCULAR
94 Volume 27 - N.º 2
The platelet count progression for the IpG and the 
PpG is presented in image 1B. In the IpG, the count rose 
in the first morning, decreased in the second (to 79% 
of the preoperative count) and then increased gradually 
to 135% of the baseline levels, at the follow-up visit. In 
the PpG, the platelet levels were maintained in the first 
morning and then decreased gradually until the fourth 
morning (to 52% of the preoperative count); Afterwards, 
a slow recover occurred, with levels reaching 95% of the 
preoperative count at the follow-up visit. The differences 
between groups were statistically significant starting at 
the second morning. 
 
DISCUSSION 
As expected, regardless of the type of valve 
implanted, a platelet-count drop that reached a mini-
mum between the second and third postoperative days, 
was observed. This drop was statistically significant when 
compared to the preoperative values. The preoperative 
and within 1-hour platelet count were very similar in 
both valves. After the first morning, and persisting at 
the follow-up visit (~1 month), the platelet count was 
higher in the IG: the lowest count was 67% and 54% 
of the preoperative count in the IG and the PG, respec-
tively. Afterwards, the recovery was slower in the PG. 
The patients that received platelet transfusion had low 
baseline platelet count, but the overall progression and 
differences between valve groups was similar. Despite 
lower count in the groups that received Perceval valves 
(PG and PpG), bleeding and surgical exploration was not 
different between Perceval and Intuity groups. Platelet 
transfusion resulted in a significant increase in platelet 
count in the patients that receive an Intuity valve. This 
was not observed in the patients that received a Perce-
val valve. Higher bleeding in the PpG (5.0% vs 55.0% in 
PG, p<0.001) could result in platelet consumption and 
explain the “no increase” of platelets after transfusion, 
however, the IpG also had more bleeding than IG (3,9% 
Table 2 Surgical and post-operative outcomes. 










Aorta Clamping (minutes) 27.2 ± 6.8 28.7 ± 8.4 0.260 29.9 ± 12.0 26.6 ± 6.0 0,165
Cardiopulmonary bypass 
(minutes) 35.9 ± 8.7 39.7 ± 11.0 0.022 39.8 ± 16.4 36.2 ± 8.0 0,408
Operative time (minutes) 86.9 ± 20.3 95.9 ± 21.8 0.010 91.4 ± 26.8 91.2 ± 12.8 0,955
In-hospital stay
ICU stay (days) 2.6 ± 1.5 2.7 ± 1.8 0.518 4.0 ± 3.2 4.0 ± 2.9 0.953
Hospital stay (days) 5.6 ± 2.8 6.3 ± 1.8 0.107 8.2 ± 5.7 7.9 ± 4.6 0.825
Post-operative complications
Fresh plasma transfusion1 7.8% 1.7% 0.156 69.2% 40.0% 0.049
Red blood cell transfusion1 11.8% 11.7% 0.999 69.2% 70.0% 0.999
Abnormal bleeding2 3.9% 5.0% 0.711 64.1% 55.0% 0.578
Bleeding in the first 24h (ml) 466 ± 251 443 ± 363 0.635 1012 ± 466 1052 ± 757 0.829
Surgical exploration for 
bleeding 2.0% 0% 0.531 10.3% 5.0% 0.653
Significant renal dysfunction3 4.9% 8.3% 0.501 20.5% 15.0% 0.734
Renal replacement support4 1.0% 1.7% 0.999 2.6% 5.0% 0.999
Aminergic support5 >24h 19.6% 21.7% 0.840 38.5% 45% 0.780
Infection6 2.0% 5.0% 0.360 12.8% 15.0% 0.999
ICU - Intensive care unit.
Categorical variables are presented as percentage of subjects in each category and compared with t-student tests. Continuous variables were treated as mean and standard deviation 
and compared with Fisher’s exact tests.
1 Transfusion of at least 1 unit.
2 Abnormal bleeding was defined as > 2ml/kg/h in first 2-3 hours, > 1ml/kg/h in the next 3 hours and/or > 0.5ml/kg/h in 12 hours.
3 Significant renal dysfunction was defined as KDIGO stages 2 and 3.
4 Renal replacement support was performed though Continuous Veno-Venous Hemodiafiltration.
5 Aminergic support was performed with at least one of the following: epinephrine, norepinephrine, dobutamine.
6 Respiratory, urinary and/or blood infection.
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vs 64.1%, p<0.001) and a significant increase was found 
after the transfusion. On the other hand, the low number 
of patients in the PpG may not be enough to represent 
the true response. 
The results of this study suggest that, compared 
to those who received an Intuity valve, in the patients 
that received a Perceval valve: there was one (or more) 
factor(s) that negatively affect the postoperative platelet 
count; and the higher drop in platelet count was transient 
and not enough to increase the risk of bleeding events. 
Platelet count and quality can be influenced by 
multiple preoperative, intraoperative and postoperative 
factors. Low preoperative count of platelets, intraope-
rative factors and postoperative renal dysfunction and 
infection were similar between groups (IG vs PG and IpG 
vs PpG). Extracorporeal circulation time was overall short 
in all groups and the differences were small (3.8 minutes 
higher in the PG [vs IG] and 3.6 minutes higher in the 
IpG [vs IgP]), therefore this is unlikely the cause. More 
patients in the IG had coronary disease (vs PG) and were 
under antiplatelet drugs. For this reason, preoperative 
antiplatelet drugs cannot explain the drop of platelets 
in the PG. Heparin-induced thrombocytopenia was not 
investigated in this study, but it is unlikely that more 
patients in the Perceval groups were randomly affec-
ted. As for postoperative drugs, including antiaggregant 
drugs, the same therapeutic protocol was applied to all 
patients. One possible explanation for these results is 
the valve itself. The Perceval valve was compared to the 
Intuity valve by Jiritano and colleges10 and Magna Ease 
by Mujtaba and colleges.11 In both cases, the Perceval 
valve was also associated to a significant, but transient, 
greater reduction in platelets count, in comparison to 
Edward’s valves. The same was found by Stanger and 
colleges12 when they compared Freedom, Perceval S and 
SOLO valves with non-Sorin valves (mechanical valves, 
Magna, 3f Enable). As previously mention in the Methods 
section, the Perceval valve is derived from the stentless 
Pericarbon Freedom and Freedom SOLO valves and pre-
sents the same intense postoperative platelet count drop 
phenomenon.13,14 This phenomenon has been on study 
and debate over the last decade. Platelet activation by 
anticalcification or storage components (such as homo-
cysteic acid)12,15, mechanical stress of the prosthesis on 
the platelet15 and activation/rupture by the naked nitinol 
stent10,11 have been proposed as possible causes. The last 
two are very unlikely, since the valve has excellent hemo-
dynamic performances and if the stent was the problem, 
this phenomenon would not occur with the Pericarbon 
Freedom and Freedom SOLO valves, which are stentless. 
Strong evidences presented by Stanger and colleges12,15 
suggested that the underlying cause of the severe pos-
toperative platelet count drop associated with Sorin val-
ves was the anticalcification treatment with homocysteic 
acid. The hypothesis stated that after cardiopulmonary 
bypass some of the platelets become particularly suscep-
tible to damage and stimulation; once in contact with 
valve, N-methyl-D-aspartic acid (NMDA)-type glutamate 
receptors on these “high sensitive” platelets were acti-
vated by the homocysteic acid, leading to its lysis. On 
Figure 1 Comparison of the platelet count in the patients implanted with an Intuity valve and a Perceval valve. The patients that did not received platelet transfusion (A) and those who received platelet transfusion (B) were analyzed separately. 
PT – Platelet transfusion; <1h Pos-Op – Within 1-hour after surgery; Pre.Op – Preoperative.
A B
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the other hand, the platelets not activated by the car-
diopulmonary bypass were not affected and remained 
functionally intact, limiting the potential bleeding com-
plications. In our study, as previously mentioned, platelet 
transfusion did not result in an increase in platelet count 
in the patients that receive a Perceval valve. Assuming 
this result was not a bias of small numbers, based on 
the previous hypothesis, we could extrapolate that the 
transfused platelets also became “high sensitive” during 
the production or delivery process and reacted to the 
homocysteic acid (or other unknown element). At the 
moment, we have no further data to support this idea; 
more studies are needed. Nevertheless, a reassuring fact 
emerges: the effect of the Perceval valve on platelets does 
not appear to increase the bleeding risk. 
Study limitations 
The limitations of this study were linked to the 
use of data from a single institution, a limited number 
of cases and data and a different number of patients 
between groups. Also, it was a retrospective study and 
only early outcomes were studied.
CONCLUSION 
Compared to the Intuity valve, the Perceval valve is 
associated with a transient, but significant, drop in pla-
telet count. This drop was not associated to an increased 
risk of bleeding neither in the transfuse group nor the 
non-transfused group. Platelet transfusion, in this set-
ting, should be judicious and not only ruled by absolute 
values.
